Use of certain biologics or disease modifying antirheumatic drugs may be associated with cancer risk
The use of rituximab, abatacept and Janus kinase inhibitors (JAKis) in individuals with rheumatoid arthritis (RA) was ...
A history of endometriosis and uterine fibroids in women was associated with a greater risk of premature mortality and ...
Dagan and colleagues developed machine learning (ML) models using retrospective patient data to identify potential hepatitis ...
Children living with inflammatory bowel disease (IBD) are at greater risk of venous thromboembolism (VTE) compared to children without VTE, with the highest risk occurring around time of diagnosis. Ev ...
In this cross-sectional survey, poor control over patient load, team composition, and clinical schedule were each associated ...
In this randomized controlled trial, among patients with moderate Dupuytren’s contracture, collagenase injection was not ...
Both electroacupuncture and acupuncture alleviated symptoms of cold hypersensitivity in the hands and feet and increased ...
1. In this randomized trial, amivantamab-lazertinib led to significantly longer progression-free survival than osimertinib therapy for mutated advanced non-small-cell lung cancer (NSCLC). 2.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback